Whither funding for Independent Drug R&D Cos.?

Posted on June 13, 2008

Businessworld has an article examining the implication of the reported pull out by PE firms from their R&D joint venture with Dr. Reddy's Labs, Perlecan Pharma. The absence of a dedicated separate management team for standalone research entities like Perlecan may also be partly to blame, says Nangra. Perlecan remained a paper entity with neither a dedicated management, nor its own office. These...